Scarica l'app Stockscreener
12.18
0.66%
0.08
Precedente Chiudi:
$12.10
Aprire:
$12.02
Volume 24 ore:
88,640
Relative Volume:
0.79
Capitalizzazione di mercato:
$157.25M
Reddito:
$14.48M
Utile/perdita netta:
$-26.11M
Rapporto P/E:
-5.3915
EPS:
-2.2591
Flusso di cassa netto:
$-23.86M
1 W Prestazione:
-0.25%
1M Prestazione:
-12.69%
6M Prestazione:
-28.69%
1 anno Prestazione:
-34.52%
Intervallo 1D:
$12.02
$12.33
Intervallo di 1 settimana:
$11.84
$12.89
Portata 52W:
$11.84
$19.70
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD vs VRTX, REGN, MRNA, ARGX, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
12.18 | 157.25M | 14.48M | -26.11M | -23.86M | -2.2591 |
VRTX
Vertex Pharmaceuticals Inc
|
535.17 | 135.64B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
819.09 | 84.33B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
202.63 | 80.90B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
875.76 | 55.07B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
382.27 | 43.24B | 5.76B | 514.49M | 1.10B | 4.4813 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2025-05-02 | Iniziato | Alliance Global Partners | Buy |
| 2025-02-28 | Iniziato | Craig Hallum | Buy |
| 2024-07-16 | Reiterato | Maxim Group | Buy |
| 2022-12-22 | Iniziato | Maxim Group | Buy |
| 2022-07-18 | Ripresa | Oppenheimer | Outperform |
| 2020-09-23 | Iniziato | BTIG Research | Buy |
| 2016-11-28 | Iniziato | Aegis Capital | Buy |
| 2016-08-17 | Iniziato | Wells Fargo | Outperform |
| 2014-04-16 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Mediwound Ltd Borsa (MDWD) Ultime notizie
Precision Trading with Mediwound Ltd. (MDWD) Risk Zones - Stock Traders Daily
Precision Trading with Mediwound Ltd. (MDWD) Risk Zones - Stock Traders Daily
Avoiding Lag: Real-Time Signals in (MDWD) Movement - Stock Traders Daily
Mediwound Ltd Ord Sh (MDWD-Q) Stock Price and News - The Globe and Mail
Weekly Recap: DoD funding for NexoBrid and VALUE Phase III reassessment - TradingView
TD Cowen reiterates MediWound stock rating ahead of trial data By Investing.com - Investing.com Canada
TD Cowen reiterates MediWound stock rating ahead of trial data By Investing.com - Investing.com Australia
TD Cowen reiterates MediWound stock rating ahead of trial data - Investing.com
MediWound Ltd. (MDWD) Stock Price, News, Quote & History - Yahoo! Finance Canada
MediWound Ltd. Receives Additional $3.3 Million from U.S. Department of War to Advance Room-Temperature-Stable Formulation of NexoBrid - marketscreener.com
MDWD Looks 11.4% Overvalued on GF Value™ - GuruFocus
Understanding the Setup: (MDWD) and Scalable Risk - Stock Traders Daily
Why the Pentagon Keeps Funding This Small Cap (Nasdaq: MDWD) - benzinga.com
MediWound receives $3.3M from DoD for NexoBrid development By Investing.com - Investing.com Canada
MediWound receives $3.3M from DoD for NexoBrid development - Investing.com
MediWound receives $3.3M from DoD for NexoBrid development By Investing.com - Investing.com Nigeria
MediWound Awarded Additional $3.3 Million from U.S. - GlobeNewswire
MediWound Awarded Additional $3.3 Million from U.S. - GlobeNewswire
A $21.8M program is developing burn care that can stay at room temperature - Stock Titan
MediWound Awarded Additional $3.3 Million from U.S. - globenewswire.com
MediWound Awarded Additional $3.3 Million from U.S. Department of War to Advance Room-Temperature-Stable Formulation of NexoBrid® - Yahoo Finance
Why the Pentagon Keeps Funding This Small Cap (Nasdaq: MDWD) - TradingView
TD Cowen Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $25 - Moomoo
Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification - Yahoo Finance
Reviewers found no safety concerns in MediWound's wound trial. - stocktitan.net
Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification - GlobeNewswire
(MDWD) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Director of MediWound (NASDAQ: MDWD) trades shares via spouse - stocktitan.net
An FDA-approved burn treatment company’s CEO will join a New York fireside chat. - stocktitan.net
MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewswire
Precision Trading with Mediwound Ltd. (MDWD) Risk Zones - Stock Traders Daily
Hungarian fund owns double-digit MediWound (MDWD) stake - stocktitan.net
MediWound (NASDAQ: MDWD) seller Hess plans $50K, 3,958-share sale - stocktitan.net
New Research Estimates a $4 Billion Market by 2028, and MediWound Thinks It May Have a Solution (Nasdaq - Benzinga
MediWound (MDWD) Q2 2026 Earnings Call Transcript - AOL.ca
MediWound (MDWD) Q2 2026 Earnings Call Transcript - AOL.com
MediWound (MDWD) Q2 2026 Earnings Call Transcript - The Globe and Mail
MediWound (MDWD) Q2 2026 Results: The Available Earnings Metric Delivers a Beat in the Current Update; Closing Reaction: The Stock Records a 1.87% Increase in the Current UpdateRevenue Per Share - vinanet.vn
MediWound (MDWD) Q2 2026 Results: The Available Earnings Metric Delivers a Beat in the Current Update; Closing Reaction: The Stock Records a 1.87% Increase in the Current UpdateEarnings Forecast Report - siam.in
MediWound (MDWD) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Share-Price Check: Shares Move 1.87% Up on the DayNegative Surprise Momentum - dars.gov.et
MediWound (MDWD) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Share-Price Check: Shares Move 1.87% Up on the DayProfit Growth Outlook - vinanet.vn
What is HC Wainwright's Forecast for MediWound Q3 Earnings? - MarketBeat
MediWound (MDWD) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Share-Price Check: Shares Move 1.87% Up on the DayCost Structure Review - dars.gov.et
Weekly Recap: Reaffirmed 2026 guidance and EscharEx Phase III enrollment - TradingView
MDWD Looks 30.8% Overvalued on GF Value™ - GuruFocus
MDWD Looks 30.8% Overvalued on GF Value™ - GuruFocus
Mediwound Ltd (MDWD) Stock News Today - TradingKey
MediWound Ltd. (NASDAQ:MDWD) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates - simplywall.st
MediWound Ltd. (NASDAQ:MDWD) Just Released Its Second-Quarter Earnings: Here's What Analysts Think - Moomoo
Mediwound Ltd Azioni (MDWD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Mediwound Ltd Azioni (MDWD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Rubinstein Samuel | Director |
Sep 01 '26 |
Sale |
12.72 |
525 |
6,678 |
0 |
| Hess Shmuel | COO & Chief Commercial Officer |
Aug 27 '26 |
Sale |
12.92 |
3,958 |
51,149 |
0 |
| Shmulik Hess | Officer |
Aug 27 '26 |
Proposed Sale |
12.70 |
3,958 |
50,267 |
0 |
| Hess Shmuel | COO & Chief Commercial Officer |
Aug 26 '26 |
Sale |
13.00 |
1,865 |
24,245 |
0 |
| SHAMIR NACHUM | Director |
Jun 03 '26 |
Buy |
14.00 |
6,000 |
83,996 |
55,815 |
| Fox David Morton | Director |
Jun 01 '26 |
Buy |
14.11 |
3,537 |
49,901 |
22,283 |
| Rubinstein Samuel | Director |
May 29 '26 |
Buy |
14.33 |
150 |
2,150 |
2,993 |
| Hess Shmuel | Officer |
Dec 02 '25 |
Proposed Sale |
17.21 |
3,693 |
63,557 |
0 |
0.68%
3.98%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):